Hyundai Hope On Wheels Presents Yale Cancer Center at Smilow Cancer Hospital With $100,000 Hyundai Impact Award To Support Pediatric Cancer Research

Health

Hyundai Hope On Wheels® 501(c)(3) nonprofit organization celebrates its 20th year in the fight funding pediatric cancer research and will present Dr. Shilpa Hattangadi of Yale Cancer Center at Smilow Cancer Hospital with a $100,000 Hyundai Impact Award. This institution is one of 21 recipients of this year’s award, which is given to pediatric oncology departments at select children’s hospitals nationwide. The $100,000 Hyundai Impact Award will be officially presented to Dr. Hattangadi and Yale Cancer Center at Smilow Cancer Hospital on Wednesday, July 25th at 10:00 a.m.

In 2018, Hope On Wheels will award over $15 million toward pediatric cancer research and programs. This brings the organization’s donation total to $145 million since Hyundai joined the fight against pediatric cancer 20 years ago in 1998. With this latest grant, Yale School of Medicine has received more than $1,000,000 from Hope On Wheels.

“Throughout the country, talented doctors are working tirelessly to help kids fight cancer by conducting research or providing bedside care,” said Scott Fink, chairman, Hyundai Hope On Wheels Board of Directors. “Our goal at Hope On Wheels is to provide these doctors with the grant funds they need to perform their lifesaving work.”

During the event, children being treated at Yale Cancer Center’s who are battling cancer will participate in the program’s signature Handprint Ceremony, in which they’ll dip their hands in paint and place their handprints on a white canvas. Their colorful handprints on the canvas will represent their individual and collective journeys, hopes and dreams.

For more information about Hyundai Hope On Wheels and to view a complete list of this year’s grant winners, please visit HyundaiHopeOnWheels.org/research. Follow us on Facebook, Twitter or Instagram at facebook.com/HyundaiHopeOnWheels, twitter.com/HopeOnWheels or instagram.com/HyundaiHopeOnWheels.

Philanthropists Step Up With $109 Million For Alzheimer’s Research

Health

Philanthropists across the USA answered the call to accelerate the pace of Alzheimer’s research by giving an unprecedented $109 million to the Alzheimer’s Association for research, it was announced today at the Alzheimer’s Association International Conference® (AAIC®) 2018 in Chicago. Private philanthropy has enabled the Association to increase the pace of innovative research funding commitments to $160 million for more than 400 best-in-field projects in 21 countries.

“The only way we will achieve the national goal of effectively treating and preventing Alzheimer’s disease by 2025 is through research, and that is why we have led the charge to increase both public and private funding of Alzheimer’s research,” said Alzheimer’s Association President and CEO Harry Johns. “Research funding is the fuel for discovery and has changed the trajectory of heart disease, HIV and many cancers, and we are confident that this funding will do the same for Alzheimer’s disease. The Alzheimer’s Association is leading the way to ensure that the robust research pipeline has the money needed to make critical discoveries that will lead us to fulfill the national goal.”

Since 2014, nearly 140 donors, including individuals, corporations and organizations, made gifts ranging from $100,000 to $5 million for research to the Alzheimer’s Association via its philanthropic initiative Step Up the Pace: Accelerating Alzheimer’s Research.

Dick Kipper of Woody Creek, Colorado, and John Beuerlein of Clayton, Missouri, served as co-chairs of the Step Up the Pace’s first phase. “I have been active in this cause for more than two decades, and the level of enthusiasm and commitment over the past four years has been unprecedented. Donors are eager to partner with the Alzheimer’s Association because of the strategic focus of the organization to accelerate research and fund new opportunities quickly in order to fuel the discovery this cause so desperately needs,” Kipper said.

The Alzheimer’s Association is the largest nonprofit funder of Alzheimer’s disease research in the world. It is also the nonprofit with the highest impact in Alzheimer’s disease research worldwide, with its impact exceeded only by that of the U.S. and Chinese governments, according to data compiled by Thomson Reuters InCites. By increasing private philanthropy, the Association has doubled its annual funding of research projects, advancing discovery science, early detection and diagnosis, treatment and prevention.

Through Step Up the Pace, private philanthropy has enabled, expanded and enhanced 10 large-scale research projects. These include clinical trials of an innovative “drug cocktail” to treat Alzheimer’s and drug trials designed to prevent dementia symptoms before they occur.  Funded studies also include hundreds of smaller-scale investigations vetted by an international network of 6,000 dementia scientists.

The announcement comes within weeks of the U.S. Senate and House Appropriations Committees’ approval of a more than $400 million increase for Alzheimer’s and dementia research funding at the National Institutes of Health (NIH), which Alzheimer’s Association advocates have been calling for. If signed into law, this will mark the fourth consecutive year of historic increases and bring total federal funding of Alzheimer’s research to $2.3 billion annually.

“The dramatic expansion in government funding requires an equally dramatic increase in projects to feed the pipeline,” John Beuerlein added. “The Alzheimer’s Association has an unparalleled track record for identifying and funding high-potential studies early to ensure that the pipeline is wide-ranging and scientists are enthusiastic to join this field of research.”

The results of the Association’s funding efforts have also led to the Alzheimer’s Association-led U.S. POINTER study. U.S. POINTER is a two-year clinical trial to evaluate whether lifestyle interventions that simultaneously target multiple risk factors protect cognitive function in older adults (age 60-79) at increased risk for cognitive decline. It is the first such study to be conducted in a large group of Americans.

“It’s estimated that more than one-third of global dementia cases may be preventable by addressing lifestyle factors,” said Maria Carrillo, Ph.D., chief science officer at the Alzheimer’s Association. “Heart disease and some cancers can now be effectively treated and prevented with a combination of medical and behavioral management. It’s time to see if we can see the same benefits for Alzheimer’s and other dementias.”

Rising Popularity of Mobile Point-of-Sale Devices Skyrockets in a Growing Billion Dollar Industry

Telecom & Internet

According to U.S. based market research and business intelligence company, Crystal Market Research, the Mobile Point of Sale Market (mPOS) was worth USD $9.73 billion in 2014 and is expected to reach approximately USD $46.28 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 18.92% during the forecast period. mPOS devices are expected to drive an increased usage of payment cards in Global markets, such as ChinaIndia and so forth. The global POS terminals/systems market is highly fragmented across vertical markets while a POS terminal itself enhances the shopping experience for customers by minimizing the payment processing time and provides companies with information pertaining to the sales of their respective products. Active tech companies in the markets this week include Gopher Protocol Inc. (OTC:GOPH), Verifone Systems, Inc. (NYSE:PAY), PayPal Holdings, Inc. (NASDAQ:PYPL), Square (NYSE:SQ), NCR Corporation (NYSE:NCR),

Gopher Protocol Inc. (OTCQB:GOPH) BREAKING NEWS: Gopher Protocol, a company specializing in the creation of Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies, is pleased to announce that its recent acquisitions, which now comprise its fintech division, led by ECS, have been fully integrated. ECS, since the beginning of 2018 (cumulative through last week) did 2,274,195 transactions from 21,729 terminals of which 1,399,975 were billable amounting to gross revenue of $24,863,692 (unaudited).

Looking at the comparable 90 day period in 2017, ECS Prepaid had $7.5 million(unaudited) in revenue while processing 813,000 transactions over an average of 5,300 locations. ECS Prepaid’s revenue for the 90 days just prior to being acquired by Gopher was $8.5 million (unaudited) while processing 859,400 transactions. For the 90 day period post acquisition by Gopher, ECS Prepaid’s revenue was $13.3 million(unaudited) while processing over 1.1 million transactions, resulting in an increase in revenue of 77% over the comparable period in 2017. Gopher intends to continue this pattern with recent agreements for processing alignments, the addition of AT&T SIM Activation program, and increased product margins on existing core products.

“ECS Prepaid would be able to operate the ‘UGO doors’ with little impact to our current work flow with the addition of one new employee in the Springfield’s office for technical support” said Derron Winfrey, Gopher’s COO. “The UGO platform, which used third parties for processing transactions, will now use the ECS platform reducing ACH transaction costs from $0.14 to $0.02, which is expected to increase our profit margins” added Kevin Pickard, Gopher’s CFO. Read this and more news for GOPH athttp://www.marketnewsupdates.com/news/goph.html